Skip to main content

Table 1 Comparison of clinical characteristics of both groups

From: The Hemobag: the modern ultrafiltration system for patients undergoing cardiopulmonary by pass

  Group Hemobag (n = 25) Group Cell Washer (n = 25) p
Mean age (years) 65.5 ± 12.7 64.9 ± 12.1 0.865
Female 10 (40%) 10(40%) 1.000
Diabetes mellitus 9 (36%) 8 (32%) 0.765
Dislipemia 13 (52%) 15 (60%) 0.569
Hypertension 18 (72%) 17 (68%) 0.758
Peripheral vascular disease 3 (12%) 4 (16%) 1.000
Respiratory disease 4 (16%) 3 (12%) 1.000
Stroke 1 (4%) 0 1.000
NYHA III–IV class 16 (64%) 17 (68%) 0.765
Atrial fibrillation 5 (20%) 7 (28%) 0.508
Severe pulmonary hypertension (>59 mmHg) 2 (8%) 2 (8%) 1.000
Ejection fraction 57.8 ± 22 57.9 ± 32 0.990
Logistic EuroSCORE (%) 6.9 ± 8 7.5 ± 8.3 0.796
  1. NYHA, New York Heart Association.